OMND Stock Overview
Provides psychedelic therapies in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Optimind Pharma Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.015 |
| 52 Week Low | CA$0.005 |
| Beta | -0.95 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -50.00% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -96.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| OMND | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | 0.7% |
| 1Y | -50.0% | 41.3% | 21.7% |
Return vs Industry: OMND underperformed the Canadian Healthcare industry which returned 41.3% over the past year.
Return vs Market: OMND underperformed the Canadian Market which returned 21.7% over the past year.
Price Volatility
| OMND volatility | |
|---|---|
| OMND Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: OMND's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine OMND's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | David Goodman | optimindpharma.com |
Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers psychedelic-like therapies for treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It also provides medical cannabis and other alternative treatments for various medical ailments through its clinic.
Optimind Pharma Corp. Fundamentals Summary
| OMND fundamental statistics | |
|---|---|
| Market cap | CA$548.94k |
| Earnings (TTM) | -CA$990.49k |
| Revenue (TTM) | CA$111.44k |
4.9x
P/S Ratio-0.6x
P/E RatioIs OMND overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OMND income statement (TTM) | |
|---|---|
| Revenue | CA$111.44k |
| Cost of Revenue | CA$41.14k |
| Gross Profit | CA$70.31k |
| Other Expenses | CA$1.06m |
| Earnings | -CA$990.49k |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.009 |
| Gross Margin | 63.09% |
| Net Profit Margin | -888.78% |
| Debt/Equity Ratio | -321.5% |
How did OMND perform over the long term?
See historical performance and comparison